Before You Invest In Healthpeak Properties Inc. (NYSE:PEAK), Consider This Metric

In yesterday’s Wall Street session, Healthpeak Properties Inc. (NYSE:PEAK) shares traded at $17.49, up 0.98% from the previous session.

As of this writing, 20 analysts cover Healthpeak Properties Inc. (NYSE:PEAK). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $32.00 and a low of $19.00, we find $25.00. Given the previous closing price of $17.32, this indicates a potential upside of 44.34 percent. PEAK stock price is now -13.55% away from the 50-day moving average and -21.02% away from the 200-day moving average. The market capitalization of the company currently stands at $9.57B.

There are 8 analysts who have given it a hold rating, whereas 9 have given it a buy rating. Brokers who have rated the stock have averaged $24.73 as their price target over the next twelve months.

With the price target of $19, Wedbush recently initiated with Neutral rating for Healthpeak Properties Inc. (NYSE: PEAK).

In other news, Lewis Sara Grootwassink, Director bought 4,000 shares of the company’s stock on Mar 15. The stock was bought for $85,729 at an average price of $21.43. Upon completion of the transaction, the Director now directly owns 4,000 shares in the company, valued at $69960.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 07, COO Klaritch Thomas bought 1,517 shares of the business’s stock. A total of $35,204 was incurred on buying the stock at an average price of $23.21. This leaves the insider owning 344,000 shares of the company worth $6.02 million. Insiders disposed of 376,855 shares of company stock worth roughly $6.59 million over the past 1 year. A total of 0.64% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in PEAK stock. A new stake in Healthpeak Properties Inc. shares was purchased by WALLEYE CAPITAL LLC during the first quarter worth $19,254,000. POINT72 ASSET MANAGEMENT, L.P. invested $9,911,000 in shares of PEAK during the first quarter. In the first quarter, LOS ANGELES CAPITAL MANAGEMENT LLC acquired a new stake in Healthpeak Properties Inc. valued at approximately $7,979,000. TUDOR INVESTMENT CORP ET AL acquired a new stake in PEAK for approximately $7,948,000. MBB PUBLIC MARKETS I LLC purchased a new stake in PEAK valued at around $7,694,000 in the second quarter. In total, there are 925 active investors with 97.20% ownership of the company’s stock.

Wednesday morning saw Healthpeak Properties Inc. (NYSE: PEAK) opened at $17.40. During the past 12 months, Healthpeak Properties Inc. has had a low of $17.23 and a high of $28.43. The fifty day moving average price for PEAK is $20.14 and a two-hundred day moving average price translates $22.10 for the stock.

The latest earnings results from Healthpeak Properties Inc. (NYSE: PEAK) was released for Jun, 2023. According to the REIT – Healthcare Facilities Company, earnings per share came in at $0.09, missing analysts’ expectations of $0.11 by -0.02. This compares to $0.13 EPS in the same period last year. The net profit margin was 25.06% and return on equity was 8.23% for PEAK. The company reported revenue of $545.43 million for the quarter, compared to $517.93 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.31 percent. For the current quarter, analysts expect PEAK to generate $541.86M in revenue.

Moreover, the firm recently paid out its quarterly dividend on 08/18/2023. Investors who held shares on 08/07/2023 were paid a $0.30 dividend. On an annualized basis, this represents a $1.20 dividend and a 6.86% percent yield. There was an ex-dividend date of 08/04/2023 for this dividend. In terms of dividend payout ratio, PEAK is presently at 130.32%.

Healthpeak Properties Inc.(PEAK) Company Profile

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates and develops high-quality real estate for healthcare discovery and delivery.

Related Posts